Vontobel Financial Products GmbH Share Price

Certificat

DE000VM9XT56

Market Closed - Boerse Frankfurt Warrants 18:44:15 28/06/2024 BST
85.81 EUR -13.02% Intraday chart for Vontobel Financial Products GmbH
Current month-15.34%
1 month-14.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 85.81 -13.02%
27/06/24 98.65 -0.86%
26/06/24 99.51 -0.72%
25/06/24 100.2 -0.59%
24/06/24 100.8 +1.31%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 06:44 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NIKE, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9XT5
ISINDE000VM9XT56
Date issued 26/02/2024
Strike 104.5 $
Maturity 21/03/2025 (266 Days)
Parity 0.1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 101.9
Lowest since issue 85.81
Spread 6.7
Spread %0.78%

Company Profile

Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net sales break down by family of products as follows: - footwear (68.9%); - clothing (27.2%); - sports equipment (3.4%): golf equipment (golf clubs, balls, gloves, etc.), bags, balls, etc.; - other (0.5%). At the end of May 2023, products were being marketed through a network of 1,032 stores worldwide, through independent distributors, and via the Internet. Net sales are distributed geographically as follows: North America (44.3%), Europe/Middle East/Africa (27.5%), China (14.9%), Asia/Pacific and Latin America (13.2%) and other (0.1%).
Sector
-
More about the company

Ratings for Nike, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Nike, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
94.19 USD
Average target price
96.76 USD
Spread / Average Target
+2.73%
Consensus